Demonstrating the Value of Efficient PAT, AI & Machine Learning in Drug & Biologics Development & Manufacturing to Ensure Product Consistency
As demand surged for GLP-1s, small molecules, and complex biologics, the industry faced increasing pressure to innovate and optimize manufacturing processes to meet the needs of Pharma 4.0. The 4th PAT & Real Time Quality Summit offered a unique opportunity to explore how Process Analytical Technology is transforming drug development and manufacturing, ensuring product consistency and reducing waste.
Across three days, 18+ industry leaders shared case studies, discussed the latest analytical tools, and demonstrated how digital technologies can be applied throughout the biologics and drug product lifecycle to save time and money. Attendees dived into key topics, including regulatory updates, real-time release testing, and tech transfer challenges, while exploring the application of PAT for various drug modalities, including CGT, vaccines, peptides, and small molecules.
With experts from top pharma companies such as AstraZeneca, GlaxoSmithKline, and Pfizer, this summit provided an unmatched platform to discuss strategies for improving processes and accelerating the adoption of scalable, cost-effective PAT solutions.
This wad your chance to connect with other PAT practitioners and gain the insights needed to navigate the future of pharma manufacturing.
Was great to have the chance to be with leading PAT practitioners and exchange and discuss about the current trends, opportunities and challenges in the pharma business. I enjoyed many high-quality talks.
Head of Advanced Analytical Technologies, Roche
The great opportunity to meet with PAT experts and share the advances and usage of PAT and chemometrics models within my company. Delighted to have learned more on other platforms such as Biotech and Cell and Gene Therapies.
Global Statistical & PAT Lead, Novartis
Well attended with representatives from companies that are highly influential in the PAT space. Small enough of a show to make networking with others comfortable. Plenty of opportunities to share thoughts with others.
Sales & Business Development Manager, Optimal Industrial Technologies
Unlike many other professional conferences I have attended, this one had a much more collaborative environment. The information was helpful, but the peer insight was unique at this event.
Senior Principal Development Engineer, Noven Pharmaceuticals
Explore the Full 2025 Event Guide
- Get a full overview of the agenda, speakers, and sessions in one place
- View featured case studies that we shone a light on
- Discover exclusive content such as keynote highlights, attendee benefits and more
- Share easily with colleagues and decision-makers to mobilize interest
What Was New in 2025?
Interactive Regulatory Compliance Workshop
- You kickstarted your summit experience with the pre-conference workshop led by Farshid Mohammadparast of the US Pharmacopeia to discuss key recent regulations and guidelines that govern the use of PAT in manufacturing of drugs and biological products
- You gained exclusive insights into understanding model validation workflows and addressing challenges for validating models for real time release testing (RTRT)
Putting PAT in Practice
- The 2025 summit shifted from exploring what’s possible in PAT to implementing what works. The focus was on real-world PAT execution, validation, and the organizational roadblocks that often stand in the way of adoption.
- You learned about strategies for validation, scale-up, and cross-functional buy-in from leading teams at Lonza, GSK, Johnson & Johnson and many more.
2025 Partners
Previously Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.